Rimegepant (Nurtec ODT, Biohaven),a fast-acting orally disintegrating tablet, delivers quick and sustained efficacy for patients with migraine.
In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.
A new study tested the investigational drug in combination with proton pump inhibitors for patients with gastroesophageal reflux disease.
The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.
The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.
Separately, a pharmacy association executive urges Americans to receive the flu vaccine.
Regardless of naloxone availability, rural pharmacies can serve as an educational resource for individuals seeking access to the medication.
A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.
Bempedoic acid (Nexletol, Esperion) is a new lipid-lowering therapy option for patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease.
Several pharmacy groups said they will file a brief in the Supreme Court case, Rutledge v. the Pharmaceutical Care Management Association.